Context Therapeutics, Inc. (CNTX)

2.44 -0.04 (-1.61%) USD  |  NASDAQ  |  Feb 25, 12:11
More

Context Therapeutics KZ Index (Annual)

KZ Index (Annual) Chart

View KZ Index (Annual) for CNTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View KZ Index (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

KZ Index Definition

View KZ Index Definition
Start Trial

The KZ-Index (Kaplan-Zingales Index) is a relative measurement of reliance on external financing. Companies with a higher KZ-Index scores are more likely to experience difficulties when financial conditions tighten since they may have difficulty financing their ongoing operations.

Read full definition.

KZ Index (Annual) Range, Past 5 Years

View KZ Index (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

KZ Index (Annual) Benchmarks

View KZ Index (Annual) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. --
BioMarin Pharmaceutical, Inc. Upgrade
Imunon, Inc. --